SLDB Clare Kahn buys $10K worth of shares
Mar 14, 2025, 4:34 AM
0.00%
What does SLDB do
Solid Biosciences, headquartered in Charlestown, Massachusetts, develops gene therapies for Duchenne muscular dystrophy and other cardiac diseases, employing 88 staff since its IPO on January 26, 2018. Their pipeline includes multiple gene therapy candidates and novel platform technologies.
Clare Kahn bought 1,860 shares of SLDB on 11 March at $5.34 per share, worth a total of $10K. They now own 2,960 SLDB shares, or a 169% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.